Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Change in Accured Expenses (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Change in Accured Expenses for 5 consecutive years, with -$590000.0 as the latest value for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 61.66% year-over-year to -$590000.0; the TTM value through Dec 2025 reached -$7.3 million, down 133.25%, while the annual FY2025 figure was -$7.3 million, 133.25% down from the prior year.
  • Change in Accured Expenses hit -$590000.0 in Q4 2025 for Kezar Life Sciences, down from -$426000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.9 million in Q3 2023 and bottomed at -$3.6 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is -$55300.0, with a median of $130000.0 recorded in 2021.
  • Year-over-year, Change in Accured Expenses soared 379.5% in 2023 and then tumbled 2709.28% in 2025.
  • Kezar Life Sciences' Change in Accured Expenses stood at $60000.0 in 2021, then surged by 233.33% to $200000.0 in 2022, then skyrocketed by 379.5% to $959000.0 in 2023, then crashed by 260.48% to -$1.5 million in 2024, then skyrocketed by 61.66% to -$590000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$590000.0, -$426000.0, and -$2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.